Imaging Features of Toxicities by Immune Checkpoint Inhibitors in Cancer Therapy

PURPOSE OF REVIEW: With the increasing use of immune checkpoint inhibitors in cancer therapy radiographic profiling of frequent and serious immune-related adverse events (irAEs) becomes more relevant. This article reviews imaging features of irAEs induced by the anti-CTLA-4 and anti-PD-1 antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Widmann, Gerlig, Nguyen, Van Anh, Plaickner, Julian, Jaschke, Werner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Oncology (S Delorme, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594046/
https://www.ncbi.nlm.nih.gov/pubmed/28959504
http://dx.doi.org/10.1007/s40134-017-0256-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594046/
https://www.ncbi.nlm.nih.gov/pubmed/28959504
http://dx.doi.org/10.1007/s40134-017-0256-2

Ejemplares similares